EKOS Corporation receives $2.7 million grant from NIH

EKOS Corporation, a Bothell-based medical device company, announced June 7, 2010 that they received a $2.7 million grant from the National Institutes of Health (NIH) for the development of a product to provide therapy for intracerebral hemorrhagic stroke. EKOS announced a groundbreaking study for brain clot removal using their technology in February 2010.

This entry was posted in Bothell, Company_and_Client_News, EKOS, Life_Sciences. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s